R Peces1, J M Urra, M Gorostidi, C López-Larrea. Show Affiliations » 1. Service of Nephrology, Hospital Covadonga, Oviedo, Spain.
Abstract
Entities: Chemical
Mesh： See more » Graft Rejection/immunologyGraft Rejection/prevention & controlGraft Survival/drug effectsGraft Survival/immunologyHumansImmunosuppressive Agents/administration & dosageInterleukin-6/bloodKidney Function TestsKidney Transplantation/immunologyLeukocyte Count/drug effectsMethylprednisolone/administration & dosageMuromonab-CD3/administration & dosagePostoperative Complications/immunologyPostoperative Complications/prevention & controlTumor Necrosis Factor-alpha/analysis
Substances： See more » Immunosuppressive AgentsInterleukin-6Muromonab-CD3Tumor Necrosis Factor-alphaMethylprednisolone
Year: 1992 PMID： 1465877
Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066